At a synapse, the synaptic vesicle protein cysteine-string protein-a (CSPa) functions as a co-chaperone for the SNARE protein SNAP-25. Knockout (KO) of CSPa causes fulminant neurodegeneration that is rescued by a-synuclein overexpression. The CSPa KO decreases SNAP-25 levels and impairs SNARE-complex assembly; only the latter but not the former is reversed by a-synuclein. Thus, the question arises whether the CSPa KO phenotype is due to decreased SNAP-25 function that then causes neurodegeneration, or due to the dysfunction of multiple as-yet uncharacterized CSPa targets. Here, we demonstrate that decreasing SNAP-25 levels in CSPa KO mice by either KO or knockdown of SNAP-25 aggravated their phenotype. Conversely, increasing SNAP-25 levels by overexpression rescued their phenotype. Inactive SNAP-25 mutants were unable to rescue, showing that the rescue was specific. Under all conditions, the neurodegenerative phenotype precisely correlated with SNARE-complex assembly, indicating that impaired SNARE-complex assembly due to decreased SNAP-25 levels is the ultimate correlate of neurodegeneration. Our findings suggest that the neurodegeneration in CSPa KO mice is primarily produced by defective SNAP-25 function, which causes neurodegeneration by impairing SNARE-complex assembly.
Introduction
Cysteine-string protein-a (CSPa) is a synaptic vesicle protein (Buchner and Gundersen, 1997; Chamberlain and Burgoyne, 2000; Zinsmaier and Bronk, 2001 ) that contains a DnaJdomain characteristic of co-chaperones, and forms a catalytically active chaperone complex with the DnaK-domain protein Hsc70 and the tetratricopeptide-repeat protein SGT (Chamberlain and Burgoyne, 1997; Tobaben et al, 2001) . Deletion mutants of CSPa in Drosophila exhibit a temperature-sensitive phenotype that consists of neurodegeneration and synaptic dysfunction (Umbach et al, 1994; Zinsmaier et al, 1994) . Knockout (KO) of CSPa in mice produces no immediately apparent phenotype at birth, but causes progressive neurodegeneration with paralysis and death at 2-4 months of age (Fernandez-Chacon et al, 2004) . Experiments in the calyx of Held synapse that allows examination of presynaptic function at high resolution (Schneggenburger and Forsythe, 2006) revealed that at postnatal day 11 (P11), no impairment in synaptic function or neurodegeneration was detectable in CSPa KO mice (Fernandez-Chacon et al, 2004) . After P20, however, significant impairments in synaptic transmission and massive neurodegeneration were evident (Fernandez-Chacon et al, 2004) . Highly active neurons appear to be preferentially affected by neurodegeneration in CSPa KO mice, suggesting that the neurodegeneration is activity dependent (Garcia-Junco-Clemente et al, 2010) . Similar to the KO mice, heterozygous mutations in the CSPa gene in humans cause autosomal-dominant adultonset neuronal ceroid lipofuscinosis, a neurodegenerative disorder characterized by lysosomal accumulation of misfolded proteins (Nosková et al, 2011) .
Biochemically, CSPa KO mice exhibit an B40% decrease in SNAP-25 levels and an B50% reduction in SNARE-complex assembly as measured in solubilized brain lysates (Chandra et al, 2005; Sharma et al, 2011) . The decrease in SNAP-25 in CSPa KO mice is caused by increased ubiquitination and degradation of SNAP-25 (Sharma et al, 2011) ; this phenotype is temperature-sensitive, accounting for the temperature sensitivity of the Drosophila CSPa mutants (Umbach et al, 1994; Zinsmaier et al, 1994) . Moreover, the purified CSPa/Hsc70/SGT chaperone complex prevented misfolding of purified SNAP-25 in vitro in an ATP-dependent manner, demonstrating in a reconstituted system that CSPa functions as a co-chaperone for SNAP-25 folding (Sharma et al, 2011) .
However, these findings raised important new questions that are central for a molecular understanding of CSPa and of neurodegeneration. First, given that chaperones typically have many targets, is SNAP-25 the major substrate of the co-chaperone CSPa, or just one of many? Second, does the loss of functional SNAP-25 in CSPa KO mice cause the observed impairment in SNARE-complex assembly? Third, does the impairment in SNARE-complex assembly in turn produce neurodegeneration in CSPa KO mice, or are their SNARE-complex assembly deficits and their neurodegeneration separate downstream consequences of the complex action of CSPa on multiple targets?
The fact that overexpression of a-synuclein rescues the neurodegeneration of CSPa KO mice and reverses their SNARE-complex assembly deficit, but does not ameliorate their decrease in SNAP-25 levels (Chandra et al, 2005; Burre et al, 2010) , already shed light onto these questions, but did not answer them. Specifically, a-synuclein rescues the SNARE-complex assembly deficit in CSPa KO mice by acting as a non-enzymatic chaperone for SNARE-complex assembly (Burre et al, 2010) . Since in this activity a-synuclein rescues both the SNARE-complex assembly deficit and the neurodegeneration of CSPa KO mice, this observation supports the notion that the decrease in SNARE-complex assembly was the sole cause of neurodegeneration in CSPa KO mice. However, this result does not reveal whether the decrease in SNAP-25 levels in CSPa KO mice actually causes their impairment in SNARE-complex assembly, nor does it exclude alternative hypotheses for the genesis of the neurodegeneration. For example, it is possible that the impairment in SNARE-complex assembly in CSPa KO mice and the rescue of this impairment by a-synuclein are due to multiple indirect effects of these proteins. The CSPa KO could generate a toxic protein product, such as a protein aggregate or a misfolded protein, which might cause neurodegeneration but be neutralized by the non-specific surfactant-like activity of a-synuclein. The mechanism of neurodegeneration in CSPa KO mice is an important question not only because it sheds light onto the function of the evolutionarily ancient CSPa-chaperone system, but also because few neurodegenerative pathways have been defined at the molecular level. Understanding how precisely one form of neurodegeneration occurs may offer insights into neurodegenerative mechanisms in general.
Here, we have addressed these questions using a combination of genetic, molecular, and cell biological techniques, and tested the in vivo significance of SNAP-25 chaperoning by CSPa. Our data reveal that the SNARE-complex assembly impairment and the neurodegeneration in CSPa KO mice can be fully accounted for by the loss of functional SNAP-25 in these mice. This result suggests that SNAP-25 is the major substrate of the CSPa co-chaperone activity, and that the SNARE-complex assembly deficit is the predominant cause of neurodegeneration in CSPa KO mice. We propose a model whereby the distinct chaperone activities of CSPa and a-synuclein are required to maintain SNARE-protein function during continuous neurotransmitter release reactions. According to this model, neurodegeneration ensues in the absence of SNARE-complex chaperoning because of an imbalance between reactive SNARE proteins, not because of a change in neurotransmitter release. Thus, neurodegeneration caused by the CSPa KO may provide a paradigm for a more general role of presynaptic membrane traffic in neurodegeneration.
Results
Genetic decrease in SNAP-25 levels aggravates the CSPa KO phenotype CSPa KO mice exhibit a decrease in SNAP-25 levels and in SNARE-complex assembly as early as postnatal day 5 (P5), long before neurodegeneration becomes apparent (Supplementary Figure S1A-D; Chandra et al, 2005; Sharma et al, 2011) . As a first step towards determining whether neurodegeneration in CSPa KO mice is due to the loss of functional SNAP-25 resulting in impaired SNARE-complex assembly, we crossed CSPa KO mice (Fernandez-Chacon et al, 2004) with SNAP-25 KO mice (Washbourne et al, 2002) . Heterozygous deletion of SNAP-25 by itself did not impair motor coordination or survival (Figure 1A -C; Supplementary Figure S1E ). However, heterozygous deletion of SNAP-25 on top of the CSPa KO dramatically aggravated the motor deficits of CSPa KO mice, and decreased the survival time of CSPa KO mice B2-fold (note that homozygous SNAP-25 KO mice die at birth, and thus could not be analysed (Washbourne et al, 2002) ).
We next examined the effect of the combination of SNAP-25 and CSPa KO alleles on SNAP-25 levels. In addition, we probed 25 other proteins with functions related to synaptic vesicle exo-and endocytosis in order to address the possibility that CSPa is a co-chaperone for other proteins. Furthermore, we also examined in these experiments CSPa KO mice in which the neurodegeneration was rescued by transgenic overexpression of a-synuclein using transgenic asynuclein mice with wild-type (WT) CSPa expression as a control; testing these mice allowed us to differentiate between effects induced by a loss of SNAP-25 versus an impairment of SNARE-complex assembly versus an overexpression of a-synuclein. Using quantitative immunoblotting with 125 I-labelled secondary antibodies (Rosahl et al, 1995) to accurately determine protein levels, we found that heterozygous SNAP-25 KO mice exhibited an B40% decrease in SNAP-25 protein levels ( Figure 1D ), corresponding to the decrease in SNAP-25 mRNA levels (Supplementary Figure  S1F) . CSPa KO exhibited a similar decrease in SNAP-25 protein levels ( Figure 1D ) but not in mRNA levels, consistent with the increased degradation of SNAP-25 (Sharma et al, 2011) . SNAP-25 protein levels were further decreased in the compound SNAP-25/CSPa mutants ( Figure 1D ). Besides SNAP-25, Hsc70 was decreased whenever CSPa was deleted, independent of neurodegeneration, showing that the Hsc70 decrease is not an indirect effect of neurodegeneration. In contrast, GFAP was increased and tau was decreased whenever there was neurodegeneration, indicating that their changes were caused by the neurodegeneration. aSynuclein, finally, was increased in the transgenic mice as expected. No other protein tested, especially not proteins involved in exo-and endoctyosis such as synaptotagmin, synaptophysin, dynamin, or AP180, exhibited a detectable change ( Figure 1D ; Supplementary Figure S1G ).
To correlate SNAP-25 protein levels with SNARE-complex assembly, we next measured SNARE-complex formation in the brain homogenates from the various mice. Mice hetero-*** t S y n t S y n / C S P -/-t S y n / C S P -/-t S y n / C S P -/-t S y n / C S P -/-t S y n / C S P zygous for the SNAP-25 KO exhibited no change in SNAREcomplex assembly, but heterozygous KO of SNAP-25 dramatically aggravated the SNARE-complex assembly deficit present in CSPa KO mice ( Figure 1E ; Supplementary Figure S1H and I). Transgenic a-synuclein, in contrast, rescued the SNARE-complex assembly deficit as described previously (Chandra et al, 2005) . At first glance, it may appear puzzling that similar apparent decreases in total SNAP-25 levels lead to impaired SNARE-complex assembly and to lethal neurodegeneration in homozygous CSPa KO mice but not in heterozygous SNAP-25 KO mice. However, the remaining SNAP-25 in the CSPa KO mice is likely largely misfolded and dysfunctional (Sharma et al, 2011) ; the heterozygous SNAP-25 KO thus further decreases SNARE-complex assembly in CSPa KO mice because it halves the levels of the little remaining functionally active SNAP-25.
Large decreases in SNAP-25 levels by themselves do not cause a major impairment in synaptic transmission
The worsening of the CSPa KO phenotype by heterozygous KO of SNAP-25 supports the notion that the CSPa KO phenotype is due to a loss of functional SNAP-25, resulting in impaired SNARE-complex assembly. Yet, the constitutive nature of the SNAP-25 KO and its uniform presence in all cells of the mutant mice limit the interpretation of these experiments. Thus, we generated a short-hairpin RNA (shRNA) that when expressed by a lentivirus in cultured neurons, decreased the endogenous SNAP-25 mRNA by B90% ( Figure 2A ) and the endogenous SNAP-25 protein by 480% ( Figure 2B ). Electrophysiological recordings of inhibitory postsynaptic currents (IPSCs) from SNAP-25 knockdown (KD) neurons revealed that despite the loss of most SNAP-25, neurotransmitter release induced by isolated action potentials ( Thus, a loss of the vast majority of SNAP-25 from neurons does not cause a major synaptic phenotype, as opposed to a complete loss of SNAP-25 in KO mice that blocks synaptic transmission (Washbourne et al, 2002; Bronk et al, 2007) . This surprising result suggests that the small amount of reserve SNAP-25 protein remaining in KD neurons is largely sufficient for full presynaptic function. This conclusion is consistent with the finding that CSPa KO and abg-synuclein triple KO neurons also do not exhibit a significant release phenotype prior to the onset of neurodegeneration (Fernandez-Chacon et al, 2004; Burre et al, 2010) . The question thus arises, does the SNAP-25 KD accelerate neurodegeneration induced by the loss of CSPa?
Reduction in SNAP-25 levels increases neurodegeneration in CSPa KO mice In the next set of experiments, we cultured neurons from littermate WT and heterozygous and homozygous CSPa KO mice, infected the neurons with control lentivirus or lentivirus expressing the SNAP-25 shRNA, and measured the levels of SNARE proteins after 14 days in vitro (DIV). As expected, the combination of the CSPa KO and the SNAP-25 KD decreased SNAP-25 levels below those observed with either manipulation alone, whereas the expression of other SNARE and synaptic proteins assayed was not altered ( Figure 3A ; Supplementary Figure S3 ). We then measured SNARE-complex assembly in the same samples by immunoblotting of SDS-resistant SNARE complexes ( Figure 3B ) and by immunoprecipitations ( Figure 3C ). Both methods showed that the SNAP-25 KD or the heterozygous CSPa KO alone did not significantly impair SNARE-complex assembly, whereas the combination of the heterozygous CSPa KO with the SNAP-25 KD decreased SNARE-complex assembly by B60%, indicating a synthetic effect. Moreover, addition of the SNAP-25 KD to the homozygous CSPa KO aggravated the SNARE-complex assembly deficit in the latter, producing an B90% decrease in such assembly.
To explore whether the aggravation of the CSPa KO phenotype by the SNAP-25 KD in cultured neurons translates into increased neurodegeneration in vivo, we injected concentrated lentiviruses expressing the SNAP-25 shRNA and mCherry (as a marker), or mCherry alone, into the cortex of neonatal WT mice and of heterozygous and homozygous CSPa KO mice. Neonatal mice were stereotactically injected at P1, and their brains were analysed by immunofluorescence staining at P50 to measure neuron density, synapse density, and caspase-3 cleavage during apoptosis in areas infected by the lentiviruses (Figure 4) . Comparisons of the uninjected and control-injected cortex of WT mice and of heterozygous and homozygous CSPa KO mice revealed that the homozygous CSPa KO caused an B50% reduction in the relative density of neurons (measured as the percentage of nuclei expressing the neuron-specific nuclear protein NeuN), an B40% reduction in synapse density (measured with the postsynaptic excitatory marker PSD95), an B70% increase in apoptosis (measured with cleaved caspase-3), while simultaneously producing massive astrogliosis (assayed by GFAP staining; Figure 4 ; Supplementary Figure S4 ). The heterozygous CSPa KO, conversely, had no effect on neuronal density, synapse density, or apoptosis.
We then analysed the effect of the control and SNAP-25 KD lentiviral infection on neuron numbers, synapse density, and apoptosis. Compared with the control, the SNAP-25 KD had no effect on neuron numbers, synapse density, or apoptosis in WT cortex, but caused a highly significant decrease in neuronal and synaptic density, as well as an increase in apoptosis, in the cortex of heterozygous CSPa KO mice (Figure 4) . Furthermore, the SNAP-25 KD aggravated the decrease in neuron numbers and synapse density in homozygous CSPa KO mice, while increasing apoptosis in these mice. Thus, acute suppression of SNAP-25 expression induces neurodegeneration in heterozygous CSPa KO mice, and aggravates neurodegeneration in homozygous CSPa KO mice.
Increasing SNAP-25 levels rescues the CSPa KO phenotype If the CSPa KO phenotype was primarily caused by a lack of SNAP-25 chaperoning, resulting in an impairment of SNAREcomplex assembly, it should be possible to not only aggravate the CSPa KO phenotype by further decreasing the levels of SNAP-25, but also to rescue the CSPa KO phenotype by increasing the levels of SNAP-25. If, on the other hand, the CSPa KO phenotype resulted from the combined decrease in the functions of SNAP-25 and of other proteins, then a further decrease in SNAP-25 may still be able to aggravate the phenotype, but an increase in SNAP-25 should not be able to rescue the phenotype.
To address these hypotheses, we constructed lentiviruses expressing WT SNAP-25 N-terminally fused to GFP, or two truncation mutants of SNAP-25. The SNAP-25 truncation mutants were chosen to reflect the cleavage products of botulinum toxin A (residues 1-197) and botulinum toxin E (residues 1-180); both of these truncations impair SNAP-25 function in neurotransmitter release (Huang et al, 1998; Yang et al, 2000) . In neurons, SNAP-25 is not specifically concentrated in presynaptic terminals, but is enriched in axons (Tao-Cheng et al, 2000) . When expressed in cultured neurons from CSPa KO mice, the GFP-fusion proteins of WT SNAP-25 and of the two SNAP-25 truncation mutants exhibited the same localization, with a relative enrichment in axons and exclusion from dendrites as evidenced by their co-localization with synapsin and their lack of co-localization with the dendritic marker MAP2 (Figure 5A and B; Supplementary Figure S5A) ; moreover, WT and mutant SNAP-25 GFP-fusion proteins were expressed at similar levels ( Figure 5C ; Supplementary Figures S5B and S6B) .
Strikingly, WT SNAP-25 increased SNARE-complex assembly by B200% in CSPa KO neurons, whereas the two truncation mutants of SNAP-25 had no effect ( Figure 5D-F) . In particular and different from a previous study (Yang et al, 2000) , we detected no suppression of SNARE-complex assembly by the SNAP-25 1-180 truncation mutant. Moreover, we observed no significant changes in the levels of other proteins assayed upon GFP-SNAP-25 overexpression in CSPa KO neurons except for a slight increase in vGaT levels (Supplementary Figure S5C) .
Finally, we examined the in vivo effects of SNAP-25 overexpression on neurodegeneration induced by the CSPa KO, using stereotactic injections of concentrated lentiviruses expressing SNAP-25 into mouse brains. Mice were injected at P1, and analysed at P50. Examination of neuron density, synapse density, apoptosis, and astrogliosis revealed that the neurodegeneration associated with CSPa KO was largely reversed in the cortical area expressing WT SNAP-25 ( Figure 6; Supplementary Figure S6 ). In contrast, no rescue of neurodegeneration was detected in areas expressing either GFP alone or either one of the two truncation mutants of SNAP-25.
Discussion
Previous studies revealed that KO of CSPa, a synaptic vesicle protein with a DnaJ-domain, decreases SNAP-25 levels, impairs SNARE-complex assembly, and produces neurodegeneration ( þ /À , and CSP À/À mice were infected as above, and lysates obtained at DIV14 were subjected to SNARE protein co-immunoprecipitation using Synt-1 or Syb2 antibodies, followed by immunoblotting to measure SNARE-complex assembly (left, representative immunoblots; right, quantitations). Recovered protein (relative to the input) was first normalized to the immunoprecipitated protein, and then to WT levels. Protein levels were measured by quantitative immunoblotting using 125 I-labelled secondary antibody. Data are shown as mean values±s.e.m.;, n ¼ 3 cultures; NS, not significant (P40.05); *Po0.05; **Po0.01; ***Po0.001 (using Student's t-test, comparing each test condition to the control analysed in the same experiment). as a co-chaperone that maintains the function of SNAP-25 in presynaptic terminals during repeated rounds of exo-and endocytosis involving SNARE-complex assembly and disassembly (Tobaben et al, 2001; Sharma et al 2011) . Collectively, these results identified CSPa as a novel SNARE chaperone, but raised major new questions, which we have now tried to address. Is SNAP-25 the major substrate of the co-chaperone CSPa, or just one of many? Is it the loss of SNAP-25 function that impairs SNARE-complex assembly in CSPa KO mice, or do multiple parallel changes cause this impairment? Does the impairment in SNARE-complex assembly in turn cause neurodegeneration, or are the SNARE-complex assembly deficits and neurodegeneration in CSPa KO mice separate downstream effects of the loss of multiple actions of CSPa?
In trying to address these questions, we made four principal observations: 1. Deletion of CSPa selectively alters SNAP-25 levels and SNARE-complex assembly without significantly affecting the levels of other synaptic proteins. 2. Genetic decrease in SNAP-25 expression in heterozygous SNAP-25 KO mice does not in itself produce neurodegeneration, but dramatically aggravates the SNARE-complex assembly deficit and neurodegeneration of CSPa KO mice. 3. shRNA-dependent KD of SNAP-25 in CSPa KO mice similarly decreases SNARE-complex assembly and increases neurodegeneration. 4. Overexpression of WT but not C-terminally truncated SNAP-25 rescues the CSPa KO phenotype, both in terms of the decrease in SNARE-complex assembly and in terms of the neurodegeneration.
These data strongly argue that the CSPa KO phenotype is largely if not exclusively caused by loss of CSPa-dependent chaperoning of SNAP-25, which leads to impaired SNAREcomplex assembly that in turn then causes neurodegeneration. To test this hypothesis further, we plotted the number of neurons and the density of synapses observed in the brain sections as a function of the biochemically measured SNAREcomplex assembly efficiency ( Figure 7A ). The plot shows that neuron numbers and synapse density (which in turn are a function of the degree of neurodegeneration) directly correlate with SNARE-complex assembly. Since the SNARE-complex assembly deficit precedes the neurodegeneration in CSPa KO mice, these data indicate that this deficit causes the neurodegeneration.
Although our data do not exclude the possibility that CSPa acts on other substrates besides SNAP-25, they show that the major features of the CSPa KO phenotype can be accounted for by the function of CSPa as a SNAP-25 chaperone. As a result, we propose a model whereby the neurodegeneration induced by the CSPa KO arises from an impairment in SNARE-complex assembly that in turn is the result of the À/À neurons on SNARE-complex assembly. CSP À/À cortical neuron cultures were infected with indicated lentiviruses as in (A). Lysates obtained on DIV14 were subjected to SNARE protein co-immunoprecipitation using Syb2 and Synt-1 antibodies, followed by immunoblotting to measure SNARE-complex assembly. Recovered protein (relative to the input) was first normalized to the immunoprecipitated protein, and then to GFP only expressing controls. Protein levels were determined using phosphorimager analysis with 125 I-labelled secondary antibody. Data shown are mean values ± s.e.m.; n ¼ 4 cultures; NS, not significant (P40.05); *Po0.05; **Po0.01; ***Po0.001. Statistical significance was assessed by Student's t-test, comparing each test condition to the control analysed in the same experiment. loss of SNAP-25 chaperoning ( Figure 7B ). With this model, we suggest that impaired SNARE-complex assembly does not cause neurodegeneration via a decrease in neurotransmitter release, but because the impairment in SNARE-complex assembly leads to an excess of reactive SNARE proteins that do not participate in SNARE complexes. Specifically, the loss of functional SNAP-25 in the CSPa KO mice results in a relative excess of syntaxin-1 (Synt-1) and synaptobrevin-2 (Syb2) over SNAP-25. As SNARE proteins, Synt-1 and Syb2 are highly reactive and may engage in inappropriate protein interactions that damage the nerve terminals, resulting in neurodegeneration.
Our model is supported by three major lines of evidence: First, the loss of functional SNAP-25 in CSPa KO mice is solely responsible for the neurodegeneration (Figures 1-6) ; second, the level of SNARE-complex assembly precisely correlates with neurodegeneration ( Figure 7A) ; and third, the neurodegeneration in CSPa KO mice is rescued by a-synuclein overexpression (Chandra et al, 2005) , which does not restore SNAP-25 levels, but directly enhances SNARE-complex assembly (Burre et al, 2010 ).
An alternative model could be that the loss of CSPadependent SNAP-25 chaperoning generates a toxic SNAP-25 conformer, which inhibits SNARE-complex formation and/or damages the nerve terminal. According to this scenario, chaperoning of SNAP-25 would still be sufficient in heterozygous CSPa KO mice to prevent neurodegeneration, and a-synuclein overexpression rescues the CSPa KO neurodegeneration because a-synuclein may conceivably detoxify this hypothetical SNAP-25 conformer. However, the fact that the SNAP-25 KD elicits a neurodegenerative phenotype in heterozygous CSPa KO mice and that SNAP-25 overexpression rescues the CSPa KO phenotype renders this second hypothesis unlikely.
Another, less-defined alternative model could be that CSPa may generally chaperone synaptic vesicle trafficking via acting on multiple targets, and that neurodegeneration develops in CSPa KO mice because of the cumulative effects of multiple trafficking defects. However, our finding that the CSPa KO phenotype can be selectively enhanced or alleviated by manipulations that decrease or increase SNAP-25 levels, respectively, strongly argues against this model. Moreover, the observation that CSPa KO mice do not exhibit a detectable synaptic transmission defect in the calyx of Held synapse before neurodegeneration occurs rules out this hypothesis (Fernandez-Chacon et al, 2004) . In this respect, the finding that the impairment in SNARE-complex assembly in CSPa KO mice does not suffice to decrease synaptic transmission (Fernandez-Chacon et al, 2004) is consistent with our present data, showing that a large decrease in SNAP-25 levels induced by the SNAP-25 KD does not produce a major impairment in synaptic transmission (Figure 2) . Together, these observations reveal an enormous functional reserve for SNARE proteins at the synapse, in agreement with the high expression levels of these proteins. Does the neurodegenerative mechanism described here potentially apply to other forms of neurodegeneration, and is this mechanism relevant for human disease? Significant evidence points to a presynaptic locus in neurodegeneration in at least some cases of Alzheimer's and Parkinson's disease (Wishart et al, 2006; Kramer and Schulz-Schaeffer, 2007; Scheff et al, 2007) . Moreover, the widespread involvement of a-synuclein in neurodegenerative disorders (Galvin et al, 2001) and the function of a-synuclein as a SNARE chaperone (Burre et al, 2010) generally support the notion that SNARE proteins may have a role in human neurodegeneration. Yet, at this point no direct evidence for a role of impaired SNAREcomplex assembly in human neurodegeneration exists, whereas much evidence points to toxic protein fragments or conformers as causative agents in human neurodegeneration (Rubinsztein, 2006; Yankner et al, 2008) . However, the 'toxic protein' hypothesis has not yet been confirmed for any neurodegenerative disorder. Moreover, the mechanism of neurodegeneration outlined here raises the possibility that these toxic agents could act by specifically interfering with SNARE-dependent presynaptic membrane traffic, including a loss of SNARE-protein function. For example, sequestration of a-synuclein into Lewy bodies is a hallmark of several neurodegenerative diseases (Galvin et al, 2001) , and may decrease the levels of functional a-synuclein in the respective neuron. We hope that with the present description of a defined neurodegenerative pathway, a more concrete examination of these questions may now become possible.
Materials and methods

Mouse breeding experiments
CSPa KO mice were bred CSP þ /À to CSP þ /À as described (Fernandez-Chacon et al, 2004) . For analysis of the effect of decreasing SNAP-25 levels on CSPa KO mice, we first generated compound heterozygous SNAP-25 KO mice (Washbourne et al, 2002) /CSPa KO mice. The SNAP-25 and CSPa genes are both on mouse chromosome 2 (E45 Mbp, or E24 cM apart); thus, any analysis of the effect of SNAP-25 heterozygosity on the CSPa KO phenotype requires the two mutant alleles to be on the same chromosome, which necessitated extensive crossings to obtain the required recombination and confirm it in subsequent breedings. We then bred SNAP-25/CSPa double heterozygous mice either to each other, or with CSPa heterozygous mice, and analysed the survival and biochemical properties of the resulting littermate offspring (note that since homozygous SNAP-25 KO mice are lethal (Washbourne et al, 2002) , these were not present in the analysis). CSPa mice rescued by the transgenic expression of human a-synuclein (tSyn/CSP À/À ) (Chandra et al, 2005) were bred as tSyn/CSP þ /À to CSP þ /À in order to keep the transgene expression constant. The animal protocols used in this study, as well as the overall mouse and rat husbandry practices were approved by the respective Institutional Animal Care and Use Committees at UT Southwestern Medical Center and Stanford University.
Primary mouse cultured neurons
Mouse cortical neurons were cultured from newborn mice essentially as described (Tang et al, 2006; Maximov et al, 2007) . Brain regions were dissected in ice-cold Hank's Balanced Salt Solution, dissociated by trypsinization (0.05% trypsin-EDTA, for 10 min at 371C), triturated with a siliconized pipette, and plated (100 ml) onto a 12-mm coverslip (for immunofluorescence) or on 12-well plastic dishes, coated for at least 30 min with Matrigel (BD Biosciences). Plating medium (MEM (Gibco) supplemented with 5 g/l glucose, 0.2 g/l NaHCO 3 (Sigma), 0.1 g/l transferrin (Calbiochem), 0.25 g/l insulin (Sigma), 0.3 g/l L-glutamine (Gibco), and 10% fetal bovine serum) was replaced with growth medium (MEM (Gibco) containing 5 g/l glucose, 0.2 g/l NaHCO 3 (Sigma), 0.1 g/l transferrin (Calbiochem), 0.3 g/l L-glutamine (Gibco), 5% fetal bovine serum, 2% B-27 supplement (Gibco), and 2 mM cytosine arabinoside (Sigma)) 24-48 h after plating. Cultured neurons were transduced with recombinant lentiviruses and/or used for experiments as indicated.
Lentiviral vector production, transduction, and expression
Using a modified FUGW lentiviral vector (Lois et al, 2002; Pang et al, 2010) , shRNA sequence against mouse SNAP-25 mRNA (GCAATGAGCTGGAGGAGATctcaagagaATCTCCTCCAGCTCATTGCT TTTTT; loop in lower case) was expressed using the H1 promoter, followed by mCherry expressed from the ubiquitin promoter. For overexpression studies, SNAP-25 cDNA was introduced into FUGW lentiviral vector (Lois et al, 2002) to generate N-terminally GFPtagged WT SNAP-25. For the SNAP-25 truncation constructs, a stop codon was introduced in place of residue 198 or 181 to generate GFP-SNAP-25 1À197 and GFP-SNAP-25
1À180
. Lentiviral vector (containing shRNA or SNAP-25 variants), VSVG envelope glycoprotein and D8.9 HIV-1 packaging vectors were co-transfected (in a 1:1:1 molar ratio) into HEK293T cells (ATCC) in neuronal growth medium using Fugene-6 (Roche). Medium containing the viral particles was collected 48 h later and centrifuged for 10 min at 2000 r.p.m. to remove any cellular debris. The supernatant containing virions was added to cultured neurons at 5-7 DIV, and the expression of the recombinant proteins was monitored using mCherry or GFP fluorescence at 14 DIV before the beginning of the experiment.
Expression of SNAP-25 shRNA or GFP-SNAP-25 in mouse cortex
Medium containing lentiviral particles was harvested as described above, and the virions were concentrated by centrifugation at 50 000 g av for 90 min. The viral pellet was re-suspended in neuronal medium (at 1/50 of the pre-centrifugation volume) containing 4 mg/ ml polybrene (Sigma), snap-frozen in liquid N 2 and kept at À801C. Heads of neonatal mouse pups (P1) were sterilized using Betadine (Purdue Pharma) and the pups were placed on ice for 1 min to anaesthetize them (while the thawed virus solution was warmed in the palm of the hand to body temperature). In all, 10 ml of the virus solution was injected into each cortex using a sterile Hamilton syringe (Davidson et al, 2010) , feeling for the needle's passage through the soft skull. Pups were placed back with the mother immediately, and were monitored daily for negative effects of the injections (e.g. seizures, circling or paralysis, whereupon they would have been sacrificed). The injected animals were weaned at P19-21 and were transfusion fixed for brain histochemistry on P50.
Electrophysiology in cultured neurons
Whole-cell recordings in cultured neurons were conducted as described (Maximov et al, 2007) . Briefly, cortical neurons were transferred from culture medium to extracellular solution (140 mM NaCl, 5 mM KCl, 2 mM MgCl 2 , 2 mM MgCl 2 , 10 mM HEPES-NaOH pH 7.4, 10 mM glucose) at room temperature. For recordings of evoked IPSCs, AMPA receptor and NMDA receptor blockers CNQX (20 mM) and D-AP-5 (50 mM) were added in the extracellular solution. To record mIPSCs, tetrodotoxin (TTX; 1 mM) was included in the extracellular solution in addition to CNQX and APV. For recordings of mEPSCs, TTX, APV, and GABA A receptor blocker picrotoxin (50 mM) were added to the extracellular solution. Patch pipette with resistance of 2.2-3.0 MO was filled with intracellular solution (135 mM CsCl, 10 mM HEPES, 1 mM EGTA, 1 mM Na-GTP, 4 mM Mg-ATP, and 10 mM QX-314, pH 7.4, adjusted with CsOH). Neurons were clamped at -70 mV. For evoked IPSC recording, synaptic current was evoked by 90 mA/1 ms current injections via a concentric bipolar electrode (CBAEC75, FHC) placed B150 mm from the soma of patched neurons. The frequency, duration, and magnitude of the extracellular stimulus were controlled with a model 2100 Isolated Pulse Stimulator (A-M Systems) synchronized with Clampex 10.2 data acquisition software (Molecular Devices). To measure the size of readily releasable pool of synaptic vesicles, CNQX (20 mM), D-AP-5 (50 mM) and TTX were included in the extracellular solution and 0.5 M of sucrose were puffed by Picospritzer III (Dual channel, Parker) onto the recorded neurons for 30 s to evoke the release of readily releasable synaptic vesicles. Synaptic currents were monitored with a Multiclamp700B amplifier (Molecular Devices), sampled at 10 kHz and analysed offline using Clampfit 10.2 (Molecular Devices) software. using Graph Pad Prism. All other data shown are mean values± s.e.m., and were analysed by Student's unpaired two-tailed t-test to compare the data groups.
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